| J9271 | Injection, pembrolizumab, 1 mg | 9,200 | $40 | $349.6K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,220 | $40 | $198.4K |
| J9299 | Injection, nivolumab, 1 mg | 4,640 | $20 | $111.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 230 | $110 | $24.7K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 990 | $20 | $22.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 170 | $90 | $15.8K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $130 | $8.3K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 30 | $210 | $6.8K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 70 | $60 | $4.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 70 | $60 | $4.1K |